DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's Laboratories Limited
02 2Chromo Laboratories India Private Limited
03 1Hetero Drugs Limited
04 1MSN Pharmachem Private Limited
01 2ZAFIRLUKAST
02 3Zafirlukast
01 5India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-886
Start Marketing Date : 2008-02-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52562-801
Start Marketing Date : 2013-11-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52562-800
Start Marketing Date : 2012-08-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0113
Start Marketing Date : 1999-09-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50370-0008
Start Marketing Date : 2010-04-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
93
PharmaCompass offers a list of Zafirlukast API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zafirlukast manufacturer or Zafirlukast supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zafirlukast manufacturer or Zafirlukast supplier.
PharmaCompass also assists you with knowing the Zafirlukast API Price utilized in the formulation of products. Zafirlukast API Price is not always fixed or binding as the Zafirlukast Price is obtained through a variety of data sources. The Zafirlukast Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zafirlukast manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zafirlukast, including repackagers and relabelers. The FDA regulates Zafirlukast manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zafirlukast API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zafirlukast manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zafirlukast supplier is an individual or a company that provides Zafirlukast active pharmaceutical ingredient (API) or Zafirlukast finished formulations upon request. The Zafirlukast suppliers may include Zafirlukast API manufacturers, exporters, distributors and traders.
click here to find a list of Zafirlukast suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zafirlukast as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zafirlukast API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zafirlukast as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zafirlukast and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zafirlukast NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zafirlukast suppliers with NDC on PharmaCompass.
We have 4 companies offering Zafirlukast
Get in contact with the supplier of your choice:
